PRA International Experts Chair and Present at Late Phase Conference

RALEIGH, N.C., March 25 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that two of its Late Phase Services (LPS) experts made presentations during the annual Late Phase Drug Development World Americas (LPDDW) conference, which is taking place through 26 March 2010 in Princeton, New Jersey.

Maria Harrison, PRA's Global Vice President of LPS and a conference chair, provided opening remarks for the Regulatory and Policy Environment session on Wednesday, 24 March. The session also featured PRA's Jerome Wilson, MD, Senior Director of Scientific Affairs, who discussed how to demonstrate cost-effectiveness and quality of life in late phase trials.

Ms. Harrison heads PRA's global LPS group. She has more than 20 years of experience managing all aspects of drug development in both the pharmaceutical and CRO industries. Dr. Wilson develops post-approval scientific strategies and provides consulting services for marketed products. He has 20 years of scientific management experience in the pharmaceutical industry.

PRA's LPS division provides comprehensive services for all varieties of interventional and non-interventional post-marketing studies on a global scale. Our experts assist sponsors by planning and conducting safety-surveillance studies, registries, large simple trials, restricted access programs and risk management programs.

The LPDDW conference is one of the largest gatherings of pharmaceutical and biotech professionals in the United States and hosted the FDA's director of epidemiology, Dr. Danica Marinac-Dabic.

About PRA International

PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. In the last five years, PRA has supported over 2,100 clinical trials through its 37 global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit www.PRAinternational.com, email [email protected] or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International